Liver lesions in inflammatory bowel disorders
1987; Volume: 151; Issue: 4 Linguagem: Inglês
10.1002/path.1711510403
ISSN1096-9896
Autores Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoThe Journal of PathologyVolume 151, Issue 4 p. 247-255 Invited Review Liver lesions in inflammatory bowel disorders† Professor, Dr V. J. Desmet, Corresponding Author Professor, Dr V. J. Desmet University Hospital St. Rafaël, Department of Pathology, Catholic University of Leuven, Leuven, BelgiumUniversitair Ziekenhuis St. Rafaël, Laboratorium voor Histo-& Cytochemie, Minderbroedersstraat 12, B-3000 Leuven, BelgiumSearch for more papers by this authorK. Geboes, K. Geboes University Hospital St. Rafaël, Department of Pathology, Catholic University of Leuven, Leuven, BelgiumSearch for more papers by this author Professor, Dr V. J. Desmet, Corresponding Author Professor, Dr V. J. Desmet University Hospital St. Rafaël, Department of Pathology, Catholic University of Leuven, Leuven, BelgiumUniversitair Ziekenhuis St. Rafaël, Laboratorium voor Histo-& Cytochemie, Minderbroedersstraat 12, B-3000 Leuven, BelgiumSearch for more papers by this authorK. Geboes, K. Geboes University Hospital St. Rafaël, Department of Pathology, Catholic University of Leuven, Leuven, BelgiumSearch for more papers by this author First published: April 1987 https://doi.org/10.1002/path.1711510403Citations: 22 † Based on a lecture given at Southampton General Hospital on 6 June 1986. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Hoogkamp-Korstanje JAA, De Koning J, Samson JP. Incidence of human infection with Yersinia enterocolitica serotypes 03, 08, and 09 and the use of indirect immunofluorescence in diagnosis. J Infect Dis 1986; 153: 138–141. 2 Smith JN, Winship DH. Complications and extraintestinal problems in inflammatory bowel disease. Med clin North Am 1980; 64: 1161–1171. 3 Harty RF, Leibach JR. Immune disorders of the gastrointestinal tract and liver. Med clin North Am 1985; 69: 675–704. 4 Thomas GH. Ulceration of the colon with enlarged fatty liver. Trans Pathol Soc Phila 1874; 4: 87. 5 Lister TD. A specimen of diffuse ulcerative colitis with secondary diffuse hepatitis. Trans Pathol Soc London 1899; 50: 130. 6 Jankelson IR, McClure CW, Sweetsir FN. Chronic ulcerative colitis. II. Complications outside the digestive tract. Rev Gastroenterol 1942; 9: 99–104. 7 Banks BM, Korelitz BI, Zetsel L. The course of nonspecific ulcerative colitis: review of 20 years experience and late results. Gastroenterology 1957; 32: 983–1012. 8 Lockhart-Mummery HE, Morson BC. Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1960; 1: 87–105. 9 Dew MJ, Thompson H, Allain RW. The spectrum of hepatic dysfunction in inflammatory bowel disease. Q J Med 1979; 48, 113–135. 10 Warren GH, Kern F. The biliary tract in inflammatory bowel disease. Clin Gastoenterol 1983; 12: 255–268. 11 Chapman RWG, Marborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870–877. 12 Perrett AD, Higgins G, Johnston HH. The liver in ulcerative colitis. Q J Med 1971; 40: 211–238. 13 Vierling JM. Hepatobiliary complications of ulcerative colitis and Crohn's disease. In: D Zakim, TD Boyer, eds. Hepatology. A textbook of liver disease. Philadelphia: W B Saunders, 1982; 797–824. 14 Mistilis SP. Pericholangitis and ulcerative colitis. Ann intern med 1965; 63: 1–16. 15 Kimmelstiel P, Large HL, Verner HD. Liver damage in ulcerative colitis. Am J Pathol 1952; 28: 259–274. 16 Chapin LE, Scudamore HH, Baggenstoss AH. Regional enteritis: associated visceral changes. Gastroenterology 1956; 30: 404–415. 17 Stauffer MH, Sauer WG, Dearing WH. The spectrum of cholestatic hepatic disease. JAMA 1965; 191: 829–837. 18 Monto AS. The liver in ulcerative disease of the intestinal tract: functional and anatomic changes. Ann Intern Med 1959; 50: 1385–1394. 19 De Dombal FT, Goldie W, Watts JMck, Goligher JC. Hepatic histological changes in ulcerative colitis. A series of 58 consecutive operative liver biopsies. Scand J Gastroenterol 1966; 1: 220–227. 20 Schwartz SI, Dale WA. Primary sclerosing cholangitis: review and report of 6 cases. Arch Surg 1958; 77: 439–451. 21 Popper H, Paronetto F. Clinical, histologic, and immunopathologic features of primary biliary cirrhosis. Springer Semin Immunopathol 1980; 3: 339–354. 22 Schrumpf E, Elgjo K, Fausa D, Gjone E, Kolmannskog F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 1980; 15: 689–697. 23 Eade MN, Cooke WI, Brooke BN. Liver disease in Crohn's colitis. A study of 21 consecutive patients having colectomy. Ann Intern Med 1971; 74: 518–528. 24 Neville E, Pyasena KHG, James DG. Granulomas of the liver. Postgrad Med J 1975; 51: 361–365. 25 Shorvon PJ. Amyloidosis and inflammatory bowel disease. Dig Dis 1977; 22: 209–213. 26 Stromeyer FW, Ishak KG. Nodular transformation (nodular ‘regenerative’ hyperplasia) of the liver. A clinicopathologic study of 30 cases. Human Pathol 1981; 12: 60–71. 27 Wiesner RH, Ludwig J, LaRusso NF, MacCarty RL. Diagnosis and treatment of primary sclerosing cholangitis. Semin Liver Dis 1985; 5: 241–253. 28 Delbet MP. Rétrécissement du cholédoque. Cholecystoduodenostomie. Bull Soc Natl Chir (Paris) 1924; 50: 1144–1146. 29 Lancereaux E. Traité des maladies du foie et du pancréas. Paris: Ed Doin, 1889: 661–665. 30 Hoffman CEE. Verschluss der Gallenwege durch Verdickung der Wandungen. Arch Pathol Anat Physiol 1867; 49: 206–215. 31 Smith ML, Loe RH. Sclerosing cholangitis: review of recent case reports and associated diseases and four new cases. Am J Surg 1965; 110: 239–246. 32 Ament AE, Haaga JR, Wiedenmann SD, Barkmeier JD, Morrison SC. Primary sclerosing cholangitis: CT findings. J Comput Assist Tomogr 1983; 7: 795–800. 33 Goudie BM, Birnie CG, Watkinson G, MacSween RNM. A case of longstanding primary sclerosing cholangitis. J Clin Pathol 1983; 36: 1298–1301. 34 Rogé J, Guivarch P, Testas P, Rogé P. La cholangite sclérosante primitive. Sem Hǒp Paris 1985; 61: 1257–1271. 35 Sickinger K, Creutzfeldt W. Die primär stenosierende (sklerosierende) Cholangitis. Acta Hepato-Splenol 1968; 15: 153–165. 36 Gilat T, Grossman A, Bujanover Y, Rozen P. Epidemiology of inflammatory bowel disease. State of the art and etiologic inferences. In: D Rachmilewitz, ed. Inflammatory Bowel Diseases. The Hague: Martinus Nijhoff Publishers, 1982; 143–151. 37 Triger DR. Primary biliary cirrhosis: an epidemiological study. Br Med J 1980; 281: 772–775. 38 LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Primary sclerosing cholangitis. N Engl J Med 1984; 310: 899–903. 39 Cameron JL, Gayler BW, Sanfey H et al. Sclerosing cholangitis. Anatomical distribution of obstructive lesions. Ann Surg 1984; 200: 54–60. 40 Cavalli G, Pierangeli A, Bacci G, Bianchi FB, Casali AM. A study of the small intrahepatic biliary pathways in a case of primary sclerosing cholangitis. Panminerva Med 1971; 13: 66–74. 41 Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology, 1981; 1: 632–640. 42 Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 1984; 4: 105–116. 43 Klinge O. Die intrahepatische sklerosierende Cholangitis. Pathologe 1985; 6: 53–63. 44 Chlumska A, Chlumsky J, Krtek V, Jirkovska A, Pirk F, Skala I. Primary sclerosing cholangitis. Light and electron microscopy of hepatic tissue in two cases. Pathol Res Pract 1985; 179: 487–492. 45 Wiesner RH, LaRusso NF, Ludwig J, Dickson ER. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985; 88: 108–114. 46 Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200–206. 47 Wood RAB, Cuschieri A. Is sclerosing cholangitis complicating ulcerative colitis a reversible condition. Lancet 1980; ii: 716–718. 48 Quigley EMM, LaRusso NF, Ludwig J, MacSween RNM, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983; 85: 1160–1165. 49 Hopf U, Riecken EO, Zeitz M, et al. Immunologische Parameter bei Pericholangitis und Primär Sklerosierender Cholangitis mit und ohne Colitis Ulcerosa. Dtsch Med Wochenschr 1983; 108: 1515–1521. 50 Minuk GY, Angus M, Brickman CM, et al. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985: 88: 166–170. 51 Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples PJ, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150–154. 52 Chapman RW. Primary sclerosing cholangitis. J Hepatol 1985; 1: 179–186. 53 Chapman RW, Sherlock S. Clinical variants of sclerosing cholangitis and management. In: R Williams, WC Maddrey, eds. Liver London: Butterworths, 1984; 102–120. 54 Ritchie JK, Allan RN, Macartney J, et al. Biliary tract carcinoma associated with ulcerative colitis. Q J Med 1974; 43: 263–279. 55 Akwari OE, Van Heerden JA, Foulk WT, Baggenstoss AH. Cancer of the bile ducts associated with ulcerative colitis. Ann Surg 1975; 181: 303–309. 56 Longmire WP. When is cholangitis sclerosing? Am J Surg 1978; 135: 312–320. 57 Delavierre Ph, Arsac M, Vayre P, Germain M, Bourdais JP, Roux M. La cholangite sclerosante primitive relation avec le cancer des voies biliaires. Ann Gastroenterol Hepatol 1980; 16: 489–495. 58 Hagander B, Berg NO, Brandt L, Norden A, Sjolund K, Stenstam M. Hepatic injury in adult coeliac disease. Lancet 1977; 1: 270–272. 59 Fouin-Fortunet H, Duprey F, Touchais O, Hémet J, Galmiché JP, Colin R. Coeliac disease associated with primary biliary cirrhosis. Gastroenterol Clin Biol 1985; 9: 641–642. 60 Olsson R, Kagevi I, Rydberg L. On the occurrence of primary biliary cirrhosis and villous atrophy. Scand J Gastroenterol 1982; 17: 625–628. 61 Dowling RH, Henry K. Non-responsive coeliac disease. Br Med J 1972; 3: 624–631. 62 Weinbren K, Mutum SS. Pathological aspects of diffuse nodular hyperplasia of the liver. J Pathol 1984; 143: 81–92. 63 Pollock DJ. The liver in coeliac disease. Histopathology 1977; 1: 421–430. 64 Jones EA, James SP. Circulating immune complexes and the pathogenesis of primary biliary cirrhosis. Gastroenterology 1982; 83: 709–711. 65 Bernuau D. Cirrhose biliaire primitive: un puzzle immunologique. Gastroenterol Clin Biol 1984; 8: 829–832. 66 Enzinger FM, Helwig EB. Whipple's disease: a review of the literature and report of fifteen patients. Virchows Arch (Pathol Anat) 1963; 336: 238–269. 67 Fich A, Schwartz J, Braverman D, Zifroni A, Rachmilewitz D. Sulfasalazine hepatotoxity. Am J Gastroenterol 1984; 79: 401–402. 68 Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB. Does long-term home parenteral nutrition in adult patients cause chronic liver disease? J Parenter Enter Nutr 1985; 9: 11–17. 69 Bengoa JM, Hanauer SB, Sitrin MD, Baker AL, Rosenberg IH. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology 1985; 5: 79–84. 70 O'Leary JP. Hepatic complications of jejunoileal bypass. Semin Liver Dis 1983; 3: 203–215. 71 Deeg HJ, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Ann Rev Med 1984; 35: 11–24. 72 James WD, Odom RB. Graft-versus-host disease. Arch Dermatol 1983; 119: 683–689. 73 Snover DC. Acute and chronic graft versus host disease. Histopathological evidence for two distinct pathogenetic mechanisms. Human Pathol 1984; 15: 202–205. 74 Snover DC, Weisdorf SA, Vercellotti GM, Rank B, Hutton S, McGlave P. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Human Pathol 1985; 16: 387–392. 75 Berman MD, Rabin L, O'Donnell J, et al. The liver in long-term survivors of marrow-transplant chronic graft-versus host disease. J Clin Gastroenterol 1980; 2: 53–63. 76 Snover DC, Weisdorf SA, Ramsay NK, McGlave P, Kersey JH. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology 1984; 4: 123–130. Citing Literature Volume151, Issue4April 1987Pages 247-255 ReferencesRelatedInformation
Referência(s)